4.6 Article

Cutting edge: An endogenous pathway to systemic inflammatory response syndrome (SIRS)-Like reactions through toll-like receptor 4

Journal

JOURNAL OF IMMUNOLOGY
Volume 172, Issue 1, Pages 20-24

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.172.1.20

Keywords

-

Categories

Funding

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046810] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053733] Funding Source: NIH RePORTER
  3. NHLBI NIH HHS [HL 46810] Funding Source: Medline
  4. NIAID NIH HHS [AI 53733] Funding Source: Medline

Ask authors/readers for more resources

Systemic inflammatory response syndrome (SIRS) is typically associated with trauma, surgery, or acute pancreatitis. SIRS resembles sepsis, triggered by exogenous macromolecules such as LPS acting on Toll-like receptors. What triggers SIRS in the absence of infection, however, is unknown. In this study, we report that a SIRS-like response can be induced in mice by administration of soluble heparan sulfate, a glycosaminoglycan associated with nucleated cells and extracellular matrices, and by elastase, which cleaves and releases heparan sulfate proteoglycans. The ability of heparan sulfate and elastase to induce SIRS depends on functional Toll-like receptor 4, because mutant mice lacking that receptor or its function do not respond. These results provide a molecular explanation for the initiation of SIRS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available